Search





Search





Markets
/
Stocks
/
nrxp
/

NRX Pharmaceuticals Inc

NRXP

Add to Watchlist

3.150USD

+0.030+0.96%

Close 07-31 16:00（ET）Quotes delayed by 15 min

105.43MMarket Cap

LossP/E TTM

NRX Pharmaceuticals Inc

3.150

+0.030+0.96%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

NRXP Financials

See NRX Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

NRX Pharmaceuticals Inc Earnings Date

Latest Release

May 15, 2026

EPS / Forecast

-0.04/0.29

Revenue / Forecast

1.07M/25.57M

See Upcoming Earnings >>

Period

FY2025 Earnings

Revenue(YoY)

1.23M

EPS(YoY)

-1.34

43.34%

Analyst Rating

BUY

2026/08/01

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

Financial Indicators

EPS

86.83%-0.04

101.68%0.01

-79.13%-0.26

-30.56%-0.98

95.45%-0.34

-37.75%-0.74

80.01%-0.15

36.93%-0.75

-350.62%-7.37

65.09%-0.54

45.88%-0.74

---1.19

---1.64

---1.54

---1.37

----

Revenue

--1.07M

--983.00K

--242.00K

----

Net Profit

74.06%-1.43M

103.97%360.00K

-262.91%-5.89M

-122.63%-17.58M

15.56%-5.51M

-109.12%-9.08M

73.23%-1.62M

9.41%-7.90M

40.86%-6.53M

57.61%-4.34M

33.26%-6.06M

-24.85%-8.72M

17.91%-11.04M

66.74%-10.24M

75.48%-9.08M

97.27%-6.98M

-1404.73%-13.45M

-2731.67%-30.79M

-29355.90%-37.05M

-171095.97%-255.94M

Net Margin

---133.90%

--36.62%

---2433.88%

----

Gross Margin

--35.02%

--54.22%

--49.17%

----

Debt to assets ratio

----

-100.00%0.00%

-55.11%67.09%

29.54%211.49%

-38.18%110.63%

43.84%180.14%

94.60%149.46%

154.81%163.26%

219.78%178.96%

207.18%125.24%

--76.80%

--64.07%

--55.96%

--40.77%

--0.00%

----

Income Statement

Revenue

--1.07M

--983.00K

--242.00K

----

Operating profit

-26.71%-4.75M

-26.42%-4.59M

-36.27%-4.12M

47.09%-3.73M

37.53%-3.75M

17.52%-3.63M

47.97%-3.02M

11.19%-7.05M

36.43%-6.00M

55.44%-4.41M

36.46%-5.81M

17.31%-7.94M

39.92%-9.44M

81.33%-9.89M

54.52%-9.14M

43.91%-9.60M

-6566.53%-15.71M

-11999.79%-52.98M

-11791.02%-20.10M

-9343.29%-17.12M

Net Profit

74.06%-1.43M

103.97%360.00K

-262.91%-5.89M

-122.63%-17.58M

15.56%-5.51M

-109.12%-9.08M

73.23%-1.62M

9.41%-7.90M

40.86%-6.53M

57.61%-4.34M

33.26%-6.06M

-24.85%-8.72M

17.91%-11.04M

66.74%-10.24M

75.48%-9.08M

97.27%-6.98M

-1404.73%-13.45M

-2731.67%-30.79M

-29355.90%-37.05M

-171095.97%-255.94M

Balance Sheet

Current assets

1.45%7.36M

169.29%8.89M

190.96%11.95M

-5.94%4.59M

116.79%7.26M

-52.03%3.30M

-68.63%4.11M

-75.34%4.88M

-84.62%3.35M

-73.31%6.88M

-47.22%13.09M

-38.95%19.79M

-50.08%21.76M

-21.15%25.80M

-45.17%24.80M

74.89%32.41M

72875.69%43.58M

39573.53%32.71M

46483.52%45.23M

50259.98%18.53M

Total current liabilities

-23.13%25.18M

30.71%28.58M

99.98%40.59M

71.01%40.45M

73.68%32.75M

14.78%21.86M

5.03%20.30M

4.59%23.66M

-14.53%18.86M

22.22%19.05M

140.33%19.33M

219.40%22.62M

85.22%22.06M

30.71%15.59M

-78.13%8.04M

-87.75%7.08M

1750.57%11.91M

1856.16%11.92M

9596.59%36.77M

19346.26%57.80M

Total assets

56.82%11.90M

254.86%12.96M

236.08%15.00M

-8.09%4.84M

100.37%7.59M

-50.09%3.65M

-65.96%4.46M

-73.43%5.26M

-82.61%3.79M

-71.66%7.32M

-47.19%13.11M

-38.92%19.81M

-50.05%21.78M

-21.12%25.82M

-45.14%24.82M

74.87%32.43M

623.34%43.60M

440.94%32.73M

650.20%45.25M

195.47%18.55M

Total liabilities

-21.47%25.72M

7.51%28.89M

75.02%40.75M

71.01%40.45M

73.68%32.75M

41.09%26.87M

20.47%23.28M

4.59%23.66M

-14.53%18.86M

3.48%19.05M

140.33%19.33M

219.40%22.62M

85.22%22.06M

54.38%18.41M

-78.13%8.04M

-87.86%7.08M

147.77%11.91M

202.87%11.92M

1199.01%36.77M

2099.87%58.31M

Total equity

45.09%-13.82M

31.37%-15.94M

-36.83%-25.75M

-93.65%-35.62M

-66.97%-25.16M

-97.93%-23.22M

-202.75%-18.82M

-554.95%-18.39M

-5205.99%-15.07M

-258.36%-11.73M

-137.05%-6.22M

-111.08%-2.81M

-100.90%-284.00K

-64.39%7.41M

97.87%16.78M

163.75%25.35M

2497.37%31.69M

884.31%20.81M

164.93%8.48M

-1196.66%-39.77M

Cash Flow Statement

Net operating income

-23.42%-4.29M

-76.98%-3.71M

-25.37%-2.89M

-57.22%-4.03M

5.20%-3.48M

34.27%-2.10M

49.47%-2.31M

67.20%-2.56M

39.71%-3.67M

61.63%-3.19M

27.16%-4.56M

47.18%-7.81M

41.34%-6.09M

26.26%-8.32M

47.85%-6.27M

-3.95%-14.79M

-5702.25%-10.38M

-4867.85%-11.28M

-18479.47%-12.01M

-6074.35%-14.23M

Net investment

---213.00K

---249.00K

---2.56M

----

--0.00

-100.00%0.00

100.00%0.00

-100.00%0.00

100.00%0.00

0.00%1.00K

60.00%-2.00K

166.67%2.00K

-33.33%-4.00K

357.73%1.00K

-30.58%-5.00K

-7.80%-3.00K

---3.00K

98.83%-388.00

-101.25%-3.83K

88.02%-2.78K

Net financing

-54.86%3.42M

141.42%4.58M

373.52%9.73M

-55.75%1.39M

1820.25%7.58M

269.80%1.90M

236.84%2.05M

-49.93%3.14M

-84.48%395.00K

-111.03%-1.12M

-5260.71%-1.50M

829.42%6.27M

-88.93%2.54M

819495.14%10.12M

-100.07%-28.00K

-103.34%-860.00K

12762.28%22.98M

-99.44%1.24K

18722.63%37.52M

14797.88%25.76M

FAQs

What is the total revenue of NRX Pharmaceuticals Inc?



According to NRX Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 1.23M, with a year-on-year change of 1.23M.

What are the current assets of NRX Pharmaceuticals Inc?



According to NRX Pharmaceuticals Inc's FY2025 earnings report, its current assets were 8.89M, with a year-on-year change of 169.29.

What are the total assets of NRX Pharmaceuticals Inc?



According to NRX Pharmaceuticals Inc's FY2025 earnings report, its total assets of NRX Pharmaceuticals Inc were 12.96M, with a year-on-year change of 254.86.

What are the total liabilities of NRX Pharmaceuticals Inc?



According to NRX Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of NRX Pharmaceuticals Inc were 28.89M, with a year-on-year change of 7.51.

What is the total equity of NRX Pharmaceuticals Inc?



According to NRX Pharmaceuticals Inc's FY2025 earnings report, its total equity of NRX Pharmaceuticals Inc was -15.94M, with a year-on-year change of 31.37.

What is the net operating income of NRX Pharmaceuticals Inc?



According to NRX Pharmaceuticals Inc's FY2025 earnings report, its net operating income of NRX Pharmaceuticals Inc was -16.19M, with a year-on-year change of 17.84.

What is the net financing of NRX Pharmaceuticals Inc?



According to NRX Pharmaceuticals Inc's FY2025 earnings report, its net financing of NRX Pharmaceuticals Inc was 23.28M, with a year-on-year change of 210.97.

What is the Earnings Per Share (EPS) of NRX Pharmaceuticals Inc?



According to NRX Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.34, with a year-on-year change of 43.34.

What is the net income of NRX Pharmaceuticals Inc?



According to NRX Pharmaceuticals Inc's FY2025 earnings report, its net income was -28.62M, with a year-on-year change of -13.91.

What is the Return on Assets (ROA) of NRX Pharmaceuticals Inc?



According to NRX Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -344.70, with a year-on-year change of 24.78.

What is the operating profit of NRX Pharmaceuticals Inc?



According to NRX Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -16.19M, with a year-on-year change of 17.84.